The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $479,110 in first-year total cost, median $239,555.
Most frequent study sections
- Special Emphasis Panel[ZDA1 GXM-S (M2)]2
Most frequent institutions
- HIGHLAND INSTRUMENTS, INC.1
- MMJ LABS, LLC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | Biomarkers for Opioid Use Disorder (OUD)1R43DA058979-01 | DIPIETRO, LAURAWAGNER, TIMOTHY ANDREW | HIGHLAND INSTRUMENTS, INC., MA | $320,000 | ZDA1 |
| 2023 | Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)1R44DA058952-01 | BAXTER, AMY LYNN | MMJ LABS, LLC, GA | $159,110 | ZDA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.